Connor, Clark & Lunn Investment Management (CC&L)’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.68M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $3.49M | Sell |
|
|||||
|
2023
Q4 | $10.9M | Sell |
|
|||||
|
2023
Q3 | $4.95M | Buy |
|
|||||
|
2023
Q2 | $3.99M | Sell |
|
|||||
|
2023
Q1 | $5.9M | Buy |
|
|||||
|
2022
Q4 | $7.42M | Buy |
|
|||||
|
2022
Q3 | $3.12M | Sell |
|
|||||
|
2022
Q2 | $3.69M | Buy |
|
|||||
|
2022
Q1 | $3.06M | Sell |
|
|||||
|
2021
Q4 | $4.47M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $1.48M | Sell |
|
|||||
|
2013
Q4 | $1.4M | Buy |
|
|||||
|
2013
Q3 | $694K | Buy |
|